How mass spectrometric interrogation of MHC class I ligandomes has advanced our understanding of immune responses to viruses.

[1]  S. Madhi,et al.  Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus , 2023, BioDrugs.

[2]  E. Walsh,et al.  Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. , 2023, The New England journal of medicine.

[3]  H. Kestler,et al.  The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination , 2023, British Journal of Cancer.

[4]  Isaac B. Woodhouse,et al.  Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer , 2023, iScience.

[5]  G. Atwal,et al.  Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues , 2022, Frontiers in Immunology.

[6]  Tobias N. Hoheisel,et al.  Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity , 2022, iScience.

[7]  R. D. de Man,et al.  Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma , 2022, JHEP reports : innovation in hepatology.

[8]  A. Bertoletti,et al.  SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic , 2022, Immunity.

[9]  P. P. Corsetti,et al.  Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain a conserved rational immunogenic peptide , 2022, ImmunoInformatics.

[10]  M. MacCoss,et al.  Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs , 2021, Proceedings of the National Academy of Sciences.

[11]  Yoon Ki Kim,et al.  A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome , 2021, Nature Communications.

[12]  T. Elliott,et al.  Immunopeptidomic analysis of influenza A virus infected human tissues identifies internal proteins as a rich source of HLA ligands , 2021, bioRxiv.

[13]  N. Ternette,et al.  Know thy immune self and non‐self: Proteomics informs on the expanse of self and non‐self, and how and where they arise , 2021, Proteomics.

[14]  A. Purcell,et al.  Direct identification of HLA‐presented CD8 T cell epitopes from transmitted founder HIV‐1 variants , 2021, Proteomics.

[15]  Chih-Chiang Tsou,et al.  Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand , 2021, Molecular & cellular proteomics : MCP.

[16]  Ansuman T. Satpathy,et al.  Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics , 2021, Cell Reports.

[17]  S. Carr,et al.  Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics , 2021, Nature Communications.

[18]  Jennifer G. Abelin,et al.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs , 2021, Cell.

[19]  I. Ulitsky,et al.  SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis , 2021, Nature.

[20]  C. Brander,et al.  Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses. , 2021, Cell reports.

[21]  B. Haynes,et al.  Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells , 2021, Cell Reports.

[22]  S. Mallal,et al.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2020, bioRxiv.

[23]  Sri H. Ramarathinam,et al.  Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design , 2020, Nature Communications.

[24]  M. Bruno,et al.  The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design , 2020, Vaccines.

[25]  R. Aebersold,et al.  Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome , 2020, Journal of proteome research.

[26]  V. Thiel,et al.  Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.

[27]  G. MacBeath,et al.  Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein , 2020, Immunity.

[28]  H. Rammensee,et al.  SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition , 2020, Nature immunology.

[29]  P. Sopp,et al.  Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 , 2020, Nature Immunology.

[30]  P. Doherty,et al.  Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype , 2020, Proceedings of the National Academy of Sciences.

[31]  C. Brander,et al.  In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction , 2020, PLoS pathogens.

[32]  G. A. Efimov,et al.  SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors , 2020, Immunity.

[33]  F. Castiglione,et al.  A candidate multi-epitope vaccine against SARS-CoV-2 , 2020, Scientific Reports.

[34]  Xiang-rong Song,et al.  Ex vivo pulsed dendritic cell vaccination against cancer , 2020, Acta Pharmacologica Sinica.

[35]  M. Tay,et al.  The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.

[36]  C. Ye,et al.  Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. , 2019, Journal of hepatology.

[37]  G. Learn,et al.  Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection , 2019, Proceedings of the National Academy of Sciences.

[38]  D. Tscharke,et al.  Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses , 2019, Nature Communications.

[39]  David F. Boyd,et al.  Human CD8+ T cell cross-reactivity across influenza A, B and C viruses , 2019, Nature Immunology.

[40]  Bjoern Peters,et al.  Most viral peptides displayed by class I MHC on infected cells are immunogenic , 2019, Proceedings of the National Academy of Sciences.

[41]  Ilan Beer,et al.  Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome* , 2018, Molecular & Cellular Proteomics.

[42]  M. Nielsen,et al.  Predicted MHC peptide binding promiscuity explains MHC class I ‘hotspots’ of antigen presentation defined by mass spectrometry eluted ligand data , 2018, Immunology.

[43]  Sri H. Ramarathinam,et al.  Identification of Native and Posttranslationally Modified HLA‐B*57:01‐Restricted HIV Envelope Derived Epitopes Using Immunoproteomics , 2018, Proteomics.

[44]  Mathieu Courcelles,et al.  Comparison of the MHC I Immunopeptidome Repertoire of B‐Cell Lymphoblasts Using Two Isolation Methods , 2018, Proteomics.

[45]  Martin R Larsen,et al.  A Targeted LC‐MS Strategy for Low‐Abundant HLA Class‐I‐Presented Peptide Detection Identifies Novel Human Papillomavirus T‐Cell Epitopes , 2018, Proteomics.

[46]  P. Borrow,et al.  Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows , 2018, Front. Immunol..

[47]  P. Bhattarakosol,et al.  Elevated HPV16 E1 Expression Is Associated with Cervical Cancer Progression , 2018, Intervirology.

[48]  Ashwini Naik,et al.  Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution , 2017, Nature.

[49]  Markus Müller,et al.  ‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization , 2017, Front. Immunol..

[50]  Sri H. Ramarathinam,et al.  MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape , 2017, Nature Structural &Molecular Biology.

[51]  P. Kloetzel,et al.  A large fraction of HLA class I ligands are proteasome-generated spliced peptides , 2016, Science.

[52]  D. Busch,et al.  CD8+ T cells of Listeria monocytogenes‐infected mice recognize both linear and spliced proteasome products , 2016, European journal of immunology.

[53]  M. Nielsen,et al.  Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells , 2015, European journal of immunology.

[54]  I. Hoof,et al.  Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation , 2015, Front. Immunol..

[55]  Elisa Pappalardo,et al.  Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells , 2015, Journal of Virology.

[56]  Søren Buus,et al.  Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding , 2015, eLife.

[57]  D. Tscharke,et al.  Simultaneous Quantification of Viral Antigen Expression Kinetics Using Data-Independent (DIA) Mass Spectrometry* , 2015, Molecular & Cellular Proteomics.

[58]  Guang Lan Zhang,et al.  Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity , 2015, Proceedings of the National Academy of Sciences.

[59]  Daniel López,et al.  The Viral Transcription Group Determines the HLA Class I Cellular Immune Response Against Human Respiratory Syncytial Virus* , 2015, Molecular & Cellular Proteomics.

[60]  L. Jensen,et al.  Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation* , 2015, Molecular & Cellular Proteomics.

[61]  Peter A van Veelen,et al.  Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes. , 2014, Journal of proteomics.

[62]  Christian Brander,et al.  Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells , 2014, Journal of Virology.

[63]  Matthew E Monroe,et al.  In-source fragmentation and the sources of partially tryptic peptides in shotgun proteomics. , 2013, Journal of Proteome Research.

[64]  Anthony W. Purcell,et al.  Kinetics of Antigen Expression and Epitope Presentation during Virus Infection , 2013, PLoS pathogens.

[65]  Sébastien Lemieux,et al.  MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. , 2012, Blood.

[66]  Volker Brass,et al.  Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands , 2012, PloS one.

[67]  R. Berkowitz,et al.  Direct Identification of an HPV-16 Tumor Antigen from Cervical Cancer Biopsy Specimens , 2011, Front. Immun..

[68]  M. Ramos,et al.  Unusual viral ligand with alternative interactions is presented by HLA‐Cw4 in human respiratory syncytial virus‐infected cells , 2011, Immunology and cell biology.

[69]  Ilan Beer,et al.  Soluble plasma HLA peptidome as a potential source for cancer biomarkers , 2010, Proceedings of the National Academy of Sciences.

[70]  D. Keskin,et al.  A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers , 2010, The Journal of Biological Chemistry.

[71]  Ilan Beer,et al.  Multiple, Non-conserved, Internal Viral Ligands Naturally Presented by HLA-B27 in Human Respiratory Syncytial Virus-infected Cells* , 2010, Molecular & Cellular Proteomics.

[72]  M. Taneichi,et al.  Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice , 2009, Vaccine.

[73]  G. Air,et al.  HLA class I molecules consistently present internal influenza epitopes , 2009, Proceedings of the National Academy of Sciences.

[74]  Bin Li,et al.  HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition , 2008, Journal of Virology.

[75]  A. Fiander,et al.  HPV16 E629‐38‐specific T cells kill cervical carcinoma cells despite partial evasion of T‐cell effector function , 2008, International journal of cancer.

[76]  E. Caron,et al.  The MHC class I peptide repertoire is molded by the transcriptome , 2008, The Journal of experimental medicine.

[77]  Hans-Georg Rammensee,et al.  Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface*S , 2007, Molecular & Cellular Proteomics.

[78]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[79]  Albert J R Heck,et al.  Stable Isotope Tagging of Epitopes , 2006, Molecular & Cellular Proteomics.

[80]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[81]  Søren Brunak,et al.  Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation , 2002, Journal of Virology.

[82]  P. Roholl,et al.  A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway. , 2001, The Journal of general virology.

[83]  C. Bony,et al.  Identification in humans of HPV‐16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA‐B18 and determination of the HLA‐B18‐specific binding motif , 2000, European journal of immunology.

[84]  C. Herberts,et al.  A single naturally processed measles virus peptide fully dominates the HLA‐A*0201‐associated peptide display and is mutated at its anchor position in persistent viral strains , 2000, European journal of immunology.

[85]  R. Phillips,et al.  Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. , 1996, AIDS research and human retroviruses.

[86]  J. Yewdell,et al.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.

[87]  J. Lieberman,et al.  Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. , 1996, Immunology letters.

[88]  E. Padlan,et al.  H-2Dd exploits a four residue peptide binding motif , 1993, The Journal of experimental medicine.

[89]  K. Parker,et al.  Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[91]  E. Padlan,et al.  Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex , 1992, The Journal of experimental medicine.

[92]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[93]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[94]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[95]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[96]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[97]  E. Gilboa,et al.  A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. , 1991, Journal of immunology.

[98]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[99]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[100]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[101]  J. Rothbard,et al.  Recognition of influenza virus proteins by cytotoxic T lymphocytes. , 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[102]  J. Yewdell,et al.  Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. , 1988, Science.

[103]  T. Oltersdorf,et al.  Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. , 1987, The EMBO journal.

[104]  B. Jordan,et al.  H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide , 1986, Nature.

[105]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[106]  J. Davey,et al.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.

[107]  G. Shearer,et al.  Human cytotoxic T-cell responses to type A and type B influenza viruses can be restricted by different HLA antigens. Implications for HLA polymorphism and genetic regulation , 1980, The Journal of experimental medicine.

[108]  R. Zinkernagel,et al.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis , 1974, Nature.

[109]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[110]  P. Edman,et al.  A method for the determination of amino acid sequence in peptides. , 1949, Archives of biochemistry.

[111]  Ed van der Heeft,et al.  Dynamics of measles virus protein expression are reflected in the MHC class I epitope display. , 2003, Molecular immunology.

[112]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[113]  E. Unanue,et al.  Binding of immunogenic peptides to Ia histocompatibility molecules , 1985, Nature.